OSR Health (OSRHW) Interest Expenses (2023 - 2026)
OSR Health (OSRHW) posted Interest Expenses of $243289.2 for Q1 2026, down 40.43% sequentially from $408393.0 in Q4 2025, and down 97.13% YoY from $8.5 million in Q1 2025.
OSR Health (OSRHW) Interest Expenses (2023 - 2026) Analysis & Trends
OSR Health has reported Interest Expenses for 4 years, with the latest figure at $243289.2 in Q1 2026.
- Quarterly Interest Expenses fell 97.13% year-over-year to $243289.2 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (down 81.94% YoY) and the FY2025 annual result came in at $1.4 million, up 28.9% from the prior year.
- Interest Expenses retreated to $243289.2 in Q1 2026 per OSRHW's latest filing, from $408393.0 in the prior quarter.
- Over five years, Interest Expenses peaked at $8.5 million in Q1 2025 and troughed at $2070.0 in Q2 2024.
- A 4-year average of $1.0 million and a median of $225124.6 in 2025 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2025 and 2026: Interest Expenses soared 62575.53% in 2025, then tumbled 97.13% in 2026.
- Over 4 years, Interest Expenses stood at $355574.0 in 2023, then slumped by 87.06% to $46005.0 in 2024, then surged by 787.71% to $408393.0 in 2025, then plunged by 40.43% to $243289.2 in 2026.
- According to Business Quant data, Interest Expenses over the past three periods registered $243289.2, $408393.0, and $685218.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.12 Bn | 131.27 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.30 Bn | 77.31 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 62.84 Bn | 57.66 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.67 Bn | 50.53 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.43 Bn | 36.33 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 31.70 Bn | 28.39 Bn | 992.69 Mn | 82.05 Mn |
| 7 | BioNTech SE | 27.47 Bn | 9.08 Bn | 668.28 Mn | -4.89 Mn |
| 8 | Royalty Pharma | 27.16 Bn | 26.33 Bn | - | 93.62 Mn |
| 9 | Insmed | 27.03 Bn | 25.87 Bn | 358.27 Mn | 20.27 Mn |
| 10 | OSR Health | 1.40 Mn | 20.39 Mn | 86,605.00 | 199,024.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 243,289.19 |
| Mar 31, 2026 | 243,289.19 |
| Dec 31, 2025 | 408,393.00 |
| Dec 31, 2025 | 408,393.00 |
| Sep 30, 2025 | 685,218.00 |
| Sep 30, 2025 | 685,218.00 |
| Jun 30, 2025 | 206,960.00 |
| Jun 30, 2025 | 206,960.00 |
| Mar 31, 2025 | 8.49 Mn |
| Mar 31, 2025 | 8.49 Mn |
| Dec 31, 2024 | 46,005.00 |
| Dec 31, 2024 | 46,005.00 |
| Sep 30, 2024 | 9,114.00 |
| Sep 30, 2024 | 9,114.00 |
| Jun 30, 2024 | 2,070.00 |
| Jun 30, 2024 | 2,070.00 |
| Mar 31, 2024 | 13,545.00 |
| Mar 31, 2024 | 13,545.00 |
| Dec 31, 2023 | 355,574.00 |
| Dec 31, 2023 | 355,574.00 |